Lineage Cell Therapeutics sells 12M shares at $1.75 to Janus Henderson, grossing $21M

Lineage Cell Therapeutics, Inc.

Sold 12,000,000 common shares at $1.75 per share to Janus Henderson Investors in a block transaction.
Gross proceeds of $21 million before fees and expenses; net proceeds not disclosed.
Transaction executed under the company's existing at-the-market offering program.
Shares trade on NYSE American under ticker LCTX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.